Home > Quotes > HSP

Hospira Inc Stock Quote & Summary Data

HSP 
$35.74
*  
0.02
  negative  
0.06%
Get HSP Alerts
*Delayed - data as of May 17, 2013 
Exchange: NYSE
Industry: Consumer Durables
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored

1 Year Target: 32
Today's High/Low:  / 
Share Volume:
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today’s trading to the average daily volume. 1,962,325
Previous Close: $ 35.72
52 Week High /Low: $ 37.78 / $ 28.62
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. 5,914,704,523
P/E Ratio: NE
Forward P/E(1y) A widely used stock evaluation measure. For a security, the Price/Earnings Ratio is given by dividing the Last Sale Price by the Average EPS (Earnings Per Share) Estimate for the specified fiscal time period. The forward P/E refers to the value for the next full year. 17.68
Earnings Per Share (EPS) The EPS listed on our infoquote and Summary Quote page is "12-mos Rolling". EPS represents the portion of a company's profit allocated to each outstanding share of common stock. Net income (reported or estimated) for a period of time is divided by the total number of shares outstanding (TSO) during that period; See growth rate measures for EPS. Our vendor's methodology for the EPS on the infoquote and Summary Quote pages follows the EPS used by the majority of the analysts following the stock, in many cases this is EBITDA EPS. $ -0.43
Annualized dividend N/A
Ex Dividend Date N/A
Dividend Payment Date N/A
Current Yield 0 %
Beta 0.76

 Intraday Chart

5d | 1m | 6m | 12m | More Charting

ETFs with HSP as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
4.28% SPDR S&P Pharmaceuticals ETF (XPH) -0.56  (-0.97%)

We make it easy to follow the leaders. PowerShares QQQ. 100 companies at the top of innovation in one fund.


*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.

**Green highlights the top performing ETF by % change in the past 100 days.

 Company Description (as filed with the SEC)

Hospira is a provider of injectable drugs and infusion technologies that it develops, manufactures, distributes and markets globally. Through a broad, integrated product portfolio, Hospira is uniquely positioned to Advance WellnessTM by improving patient and caregiver safety while reducing healthcare costs. Hospira's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products. Hospira's broad portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. Hospira was incorporated in Delaware on September 16, 2003, as a wholly owned subsidiary of Abbott Laboratories (“Abbott”). Hospira's business first began operation as part of Abbott in the 1930s.  ... More ...  



News Headlines for HSP

Stocks Close Lower Following a Heavy Dose of Disappointing Economic Data
5/16/2013 4:29:00 PM - Knobias
Hospira To Present At BOA Merrill Lynch Conference; Webcast At 11:40 AM ET
5/15/2013 10:40:00 AM - RTT News
Markman Hearing A Likely Clearing Event For Cubist - Decision Any Day
5/14/2013 10:23:00 AM - Seeking Alpha
Synta Is Run-Up to ASCO Lung Cancer Data
5/14/2013 10:16:00 AM - TheStreet
Hospira Reappoints Dr. Sumant Ramachandra Chief Scientific Officer
5/14/2013 9:00:00 AM - PR Newswire
 

Consensus Recommendation